Isotretinoin improves acne linked to gender-affirming care, but barriers impede treatment

Isotretinoin is generally effective and well tolerated for acne treatment in patients receiving masculinizing gender-affirming care, but barriers can impede treatment success, according to a study.
“Approximately 30% of transmasculine individuals receiving testosterone treatment will develop acne, with 15% having moderate to severe disease,” John Barbieri, MD, MBA, assistant professor at Harvard Medical School, director of the advanced acne therapeutics clinic at Brigham and Women’s Hospital, co-chair of the AAD Acne Guidelines Work Group and a member of Healio’s Peer

Isotretinoin is generally effective and well tolerated for acne treatment in patients receiving masculinizing gender-affirming care, but barriers can impede treatment success, according to a study.
“Approximately 30% of transmasculine individuals receiving testosterone treatment will develop acne, with 15% having moderate to severe disease,” John Barbieri, MD, MBA, assistant professor at Harvard Medical School, director of the advanced acne therapeutics clinic at Brigham and Women’s Hospital, co-chair of the AAD Acne Guidelines Work Group and a member of Healio’s Peer